Research output per year
Research output per year
Personal profile
Fields of Science
- 318 Medical biotechnology
- Cancers
- 3111 Biomedicine
- 317 Pharmacy
International and National Collaboration
Publications and projects within past five years.
-
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Bogacheva, M., Kuivanen, S., Potdar, S., Hassinen, A., Huuskonen, S., Pöhner, I., Luck, T. J., Turunen, L., Feodoroff, M., Szirovicza, L., Savijoki, K., Saarela, J., Tammela, P., Paavolainen, L., Poso, A., Varjosalo, M., Kallioniemi, O., Pietiäinen, V. & Vapalahti, O., Mar 2024, In: Antiviral Research. 223, 15 p., 105813.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses
Feodoroff, M., Hamdan, F., Antignani, G., Feola, S., Fusciello, M., Russo, S., Chiaro, J., Välimäki, K., Pellinen, T., Branca, R. M., Lehtiö, J., D´alessio, F., Bottega, P., Stigzelius, V., Sandberg, J., Clancy, J., Partanen, J., Malmstedt, M., Rannikko, A. & Pietiäinen, V. & 2 others, , 2024, In: OncoImmunology. 13, 1, 12 p., 2407532.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
Russo, S., Feola, S., Feodoroff, M., Chiaro, J., Antignani, G., Fusciello, M., D'Alessio, F., Hamdan, F., Pellinen, T., Mölsä, R., Tripodi, L., Pastore, L., Grönholm, M. & Cerullo, V., 21 Mar 2024, In: Molecular therapy. Oncology. 32, 1, 13 p., 200766.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Feola, S., Hamdan, F., Russo, S., Chiaro, J., Fusciello, M., Feodoroff, M., Antignani, G., D'Alessio, F., Mölsä, R., Stigzelius, V., Bottega, P., Pesonen, S., Leusen, J., Grönholm, M. & Cerullo, V., 8 Mar 2024, In: Journal for ImmunoTherapy of Cancer. 12, 3, 16 p., e008342.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses
Hamdan, F., Feodoroff, M., Russo, S., Fusciello, M., Feola, S., Chiaro, J., Antignani, G., Greco, F., Leusen, J., Ylösmaki, E., Grönholm, M. & Cerullo, V., 16 Mar 2023, In: Molecular Therapy - Oncolytics. 28, p. 264-276 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Projects
- 1 Finished
-
COMPASS Era PERMED: Fenotyppisen lääkeaineseulonnan kliininen toteutus lasten syöpäsairauksien täsmälääketieteessä (COMPASS)
Kallioniemi, O. (Project manager), Pietiäinen, V. (Co-Principal Investigator), Buchwald, J. (Participant), Feodoroff, M. J. (Participant), Kuusela, S. (Participant), Merivirta, R.-M. (Participant), Mogollon Figueroa, I. (Participant), Potdar, S. (Participant), Saarela, J. (Participant) & Turunen, L. (Participant)
European Commission, Suomen Akatemia Projektilaskutus
01/01/2019 → 30/04/2023
Project: Research Council of Finland: Co-funded international programme